CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $832 | -32.1% | 50 | 0.0% | 0.00% | – |
Q2 2023 | $1,226 | +1.7% | 50 | 0.0% | 0.00% | – |
Q1 2023 | $1,206 | -18.3% | 50 | 0.0% | 0.00% | – |
Q4 2022 | $1,477 | -63.1% | 50 | -47.9% | 0.00% | – |
Q3 2022 | $4,000 | +100.0% | 96 | +35.2% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 71 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 71 | +9.2% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 65 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | 0.0% | 65 | +44.4% | 0.00% | – |
Q2 2021 | $4,000 | +300.0% | 45 | +150.0% | 0.00% | – |
Q1 2021 | $1,000 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |